We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Smartphone Imaging System Enables Early Oral Cancer Detection

By HospiMedica International staff writers
Posted on 30 Oct 2025

Oral cancer is often diagnosed at an advanced stage, reducing survival rates despite the mouth’s easy accessibility for visual exams. More...

Many dentists and hygienists can identify abnormal lesions but lack the specialized expertise to distinguish benign from potentially malignant ones, leading to delays in referral and diagnosis. To address this challenge, researchers have developed a smartphone-based imaging system that combines autofluorescence and white light imaging with artificial intelligence (AI) to guide referral decisions.

The mDOC (mobile Detection of Oral Cancer) system, developed by researchers at Rice University (Houston, TX, USA), can assist dental providers in community clinics to accurately identify oral lesions that need further evaluation by cancer specialists. Designed for use in resource-limited settings, mDOC aims to improve early detection and treatment outcomes for oral cancer through a low-cost, portable, and easy-to-use solution.

The mDOC device integrates two imaging techniques—white light and autofluorescence imaging—into a compact smartphone attachment. Autofluorescence imaging employs blue light to visualize changes in tissue fluorescence, which can indicate abnormal or precancerous growth. Because benign conditions such as inflammation can also reduce fluorescence, the device uses a deep learning algorithm that combines imaging data with patient-specific factors like age, smoking history, and lesion location to improve diagnostic accuracy and generate referral recommendations.

In the study published in Biophotonics Discovery, researchers collected data from 50 patients at two community dental clinics. Each participant had up to five oral sites imaged with the mDOC device, resulting in hundreds of images for analysis. Expert clinicians reviewed the images and provided referral recommendations, which were used as ground truth for training and testing the AI model. The team employed a “rehearsal training” strategy, incorporating new data alongside previously collected images from high-prevalence and healthy populations to enhance real-world performance.

When tested on a low-prevalence dataset, the mDOC system correctly identified 60% of sites requiring specialist referral and avoided unnecessary referrals in most other cases. Notably, the AI model outperformed dental providers, who missed all cases that required referral. Two of the five lesions misclassified by the system had resolved before specialist evaluation, suggesting mDOC’s predictions may have been clinically accurate. However, the algorithm also generated 21 false positives, highlighting the need for refinement.

With an average imaging time of only 3.5 minutes per patient, mDOC integrates smoothly into routine dental practice. The researchers envision future iterations incorporating more comprehensive patient history and improved training data to further reduce false positives. The study underscores mDOC’s potential to serve as an accessible diagnostic support tool, particularly in clinics with limited access to oral cancer specialists, helping to facilitate earlier intervention and improved patient outcomes.

Related Links:
Rice University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.